CSS »

Cerevel Therapeutics Hldng I shares owned by CSS

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by CSS from 13F filings

Historical chart of CSS investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by CSS

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 31k 42.40
2021-06-30 $1.5M 58k 25.62

More positions owned by CSS

Royal Caribbean Group Note 6.000% 8/1 (Principal)
Noble Corp Ord Shs A (NE)
Ark Etf Tr Innovation Etf Call Option (ARKK)
American Airlines Group Note 6.500% 7/0 (Principal)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mirati Therapeutics
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Splunk Note 1.125% 9/1 (Principal)
American Airls Put Option (AAL)
Ncl Corp Note 5.375% 8/0 (Principal)
Marriott Vacations Worldwide Note 1/1 (Principal)
Brookdale Sr Living Unit 11/15/2025 (BKDT)

View all positions for CSS

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I